Business Description
Poxel SA
ISIN : FR0012432516
Compare
Compare
Traded in other countries / regions
POXEL.France7PO.Germany0RA2.UKPXXLF.USA IPO Date
2016-08-29Description
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.82 | |||||
14-Day RSI | 98.75 | |||||
6-1 Month Momentum % | 16.67 | |||||
12-1 Month Momentum % | -73.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -3235.57 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PXXLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poxel SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.714 | ||
EPS (TTM) ($) | -1.143 | ||
Beta | -0.23 | ||
Volatility % | 84.42 | ||
14-Day RSI | 98.75 | ||
14-Day ATR ($) | 0.000163 | ||
20-Day SMA ($) | 0.7 | ||
12-1 Month Momentum % | -73.08 | ||
52-Week Range ($) | 0.545 - 2.6 | ||
Shares Outstanding (Mil) | 38.6 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Poxel SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Poxel SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Poxel SA Frequently Asked Questions
What is Poxel SA(PXXLF)'s stock price today?
The current price of PXXLF is $0.70. The 52 week high of PXXLF is $2.60 and 52 week low is $0.55.
When is next earnings date of Poxel SA(PXXLF)?
The next earnings date of Poxel SA(PXXLF) is 2024-09-23.
Does Poxel SA(PXXLF) pay dividends? If so, how much?
Poxel SA(PXXLF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |